Research ArticleLumbar Spine

Ceftriaxone Plus Methylprednisolone Combination Therapy Versus Methylprednisolone Monotherapy in Patients With Acute Spinal Cord Injury: A Randomized, Triple-Blind Clinical Trial

FARHAD MIRZAEI, ALI MESHKINI, BOHLOOL HABIBI, FIROOZ SALEHPOUR, EBRAHIM RAFEI, WOURIA FATHI, SEYED HAMED NASERI ALAVI, ALIREZA MAJDI, SEPIDEH RAHIGH AGHASAN and SEYED AHMAD NASERI ALAVI
International Journal of Spine Surgery October 2020, 14 (5) 706-712; DOI: https://doi.org/10.14444/7102

Article Figures & Data

Figures

  • Figure 1
    Figure 1

    Results of covariance comparison of changes in C-reactive protein (CRP) values between groups. Intervention: ceftriaxone plus methylprednisolone; control: methylprednisolone monotherapy.

  • Figure 2
    Figure 2

    Results of covariance comparison of changes in erythrocyte sedimentation rate (ESR) values between groups. Intervention: ceftriaxone plus methylprednisolone; control: methylprednisolone monotherapy.

  • Figure 3
    Figure 3

    The difference between improvement of the case and control groups based on the American Spinal Injury Association (ASIA) grading system.

  • Figure 4
    Figure 4

    Flowchart of the clinical trial. The style was adopted from Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134:657–662.

Tables

  • Table 1
  • Table 2
  • Table 3
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Ceftriaxone Plus Methylprednisolone Combination Therapy Versus Methylprednisolone Monotherapy in Patients With Acute Spinal Cord Injury: A Randomized, Triple-Blind Clinical Trial
FARHAD MIRZAEI, ALI MESHKINI, BOHLOOL HABIBI, FIROOZ SALEHPOUR, EBRAHIM RAFEI, WOURIA FATHI, SEYED HAMED NASERI ALAVI, ALIREZA MAJDI, SEPIDEH RAHIGH AGHASAN, SEYED AHMAD NASERI ALAVI
International Journal of Spine Surgery Oct 2020, 14 (5) 706-712; DOI: 10.14444/7102
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords